Your healthcare provider can assess whether your symptoms are related to Zepbound, require dose adjustment, or indicate an alternative diagnosis
Lifestyle changes, like increasing fiber, hydration, and activity, are often enough to relieve Ozempic constipation naturally without stopping treatment or reducing its benefits
Vanda CEO Mihael Polymeropoulos called the drug a familiar therapeutic agent that offers flexible dosing with a well-known safety profile. April 1 Product: AstraZenecas Voydeya Indication: Paroxysmal nocturnal haemoglobinuria AstraZeneca kicked off April with a win for its rare disease portfolio as the FDA approved Voydeya, an oral, first-in-class factor D inhibitor to treat a subset of patients with paroxysmal nocturnal haemoglobinuria (PNH)
When analyzed by individual agents, liraglutide demonstrated the strongest protective association (OR = 0.13, 95% CI: 0.050.32, p = 0.0001), followed by dulaglutide (OR = 0.26, 95% CI: 0.11-0.60, p = 0.01) and semaglutide (OR = 0.27, 95% CI: 0.080.98, p = 0.046), all of which were statistically significant
Hindustan Times
Additionally, both medications can affect appetite significantly, potentially leading to inadequate nutritional intake if not properly managed